Claims for Patent: 9,682,107

Summary for Patent: 9,682,107

Title:	Postnatal stem cells and uses thereof
Abstract:	The invention generally relates to postnatal dental stem cells and methods for their use. More specifically, the invention relates in one aspect to postnatal dental pulp stem cells, use of the cells to generate dentin, and differentiation of the cells. In another aspect, the invention relates to human postnatal deciduous dental pulp multipotent stem cells, use of the cells to generate dentin, and differentiation of the cells.
Inventor(s):	Shi; Songtao (Los Angeles, CA), Robey; Pamela Gehron (Bethesda, MD), Gronthos; Stan (South Australia, AU), Miura; Masako (Kyoto, JP)
Assignee:	The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, DC)
Application Number:	14/869,565
Patent Claims:	1. A method to produce human neural cells that express neural markers in a subject, comprising implanting into brain tissue of the subject an isolated population of human postnatal deciduous dental pulp multipotent stem cells, wherein the human postnatal deciduous dental pulp multipotent stem cells are from a postnatal deciduous tooth; human postnatal deciduous dental pulp multipotent stem cells in the population differentiate into a neural cell; human postnatal deciduous dental pulp multipotent stem cells in the population can proliferate to over 140 population doublings; and the isolated population of human postnatal deciduous dental pulp mulitpotent stem cells were expanded ex vivo, wherein the human postnatal deciduous dental pulp multipotent stem cells in the population express CD146, thereby allowing the human postnatal deciduous dental pulp cells to give rise to human neural cells that express neural markers in the brain tissue of the subject. 2. The method of claim 1, wherein human postnatal deciduous dental pulp multipotent stem cells within the population express STRO-1. 3. The method of claim 1, wherein the human postnatal deciduous dental pulp multipotent stem cells are transfected with an exogenous nucleic acid segment that encodes a heterologous product, and wherein the cells express the product. 4. The method of claim 1, wherein the postnatal deciduous tooth is an incisor. 5. The method of claim 1, wherein the isolated population of human postnatal dental pulp cells were obtained by the process of: separating pulp from a remnant crown of a human postnatal deciduous tooth; digesting the pulp in collagenase and dispase to form digested pulp; producing a single cell suspension from the digested pulp; isolating single cells that adhere to a tissue culture surface from the single cell suspension; and culturing the single cells in vitro. 6. The method of claim 1, wherein human postnatal deciduous dental pulp multipotent stem cells within the population do not express STRO-1. 7. The method of claim 1, wherein the subject has neural trauma. 8. The method of claim 1, wherein the subject has a neural degenerative disease or a physical injury. 9. The method of claim 8, wherein the neural degenerative disease is Alzheimer's disease or Parkinson's disease. 10. A method for producing neural cells in a subject, comprising implanting, into a brain of the subject, a composition comprising a biocompatible three dimensional carrier and a mixed population of human postnatal deciduous dental pulp multipotent stem cells that have been cultured ex vivo, induce formation of bone growth when implanted in vivo, and can proliferate for over 140 population doublings, wherein the human postnatal deciduous dental pulp multipotent stem cells in the population express CD146, thereby allowing the human postnatal deciduous dental pulp cells to give rise to neural cells in the brain of the subject. 11. The method of claim 10, further comprising transfecting the human postnatal deciduous dental pulp multipotent stem cells with an exogenous nucleic acid segment that encodes a heterologous product, wherein the human postnatal deciduous dental pulp multipotent stem cells express the product, prior to implanting the human postnatal deciduous dental pulp multipotent stem cells into the subject. 12. The method of claim 10, wherein the subject has neural trauma. 13. The method of claim 10, wherein the subject has a neural degenerative disease or a physical injury. 14. The method of claim 13, wherein the neural degenerative disease is Alzheimer's disease or Parkinson's disease. 15. The method of claim 10, wherein the biocompatible carrier is gelatin, a polyvinyl sponge, a collagen matrix, or a hydroxyapatite/tricalcuim phosphate ceramic. 16. The method of claim 10, wherein the composition is a sterile implantable solution. 17. The method of claim 10, wherein human postnatal deciduous dental pulp multipotent stem cells within the population express STRO-1. 18. The method of claim 10, wherein human postnatal deciduous dental pulp multipotent stem cells within the population do not express STRO-1.

Details for Patent 9,682,107

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2023-04-19